UNICORNS IN ONCOLOGY: VALUE CREATION AND ALLOCATION
DOI:
https://doi.org/10.35774/jee2024.03.455Keywords:
oncology, unicorns, value allocationAbstract
Unicorns in oncology create enormous value (over $60 billion). However, little is known about their economics. All 117 unicorns in the field of medicine and healthcare were analyzed to determine the extent to which they are oncologically significant. For the selected companies–those active in the field of oncology– location, business model, and value distribution were modeled. Twenty-two of the 117 highest-valued medical unicorns also, or predominantly, focus on oncology. With three exceptions, all are based in the USA. Their valuations range from $1.0 to $8.1 billion. By analyzing their business models further, we found eight different product/service offerings. The value added and its distribution are as follows: 60% to investors, 27% to sunk costs, 13% to management, and 1% to data providers. Oncological health tech unicorns create enormous value, but whether this value creation flows into the care system or is extracted from it is an open question.
JEL: I11.
References
Atomico. (2024). The state of European Tech 2020. https://soet-pdf.s3.eu-west- 2.amazonaws.com/State_of_European_Tech_2020.pdf
CBInsights. (2024). The complete list of unicorn companies. https://www.cbinsights.com/ research-unicorn-companies
Cristea, I. A., Cahan, E. M., & Ioannidis, J. P. A. (2019). Stealth research: Lack of peer-reviewed evidence from healthcare unicorns. European Journal of Clinical Investigation, 49(4), e13072. https://doi.org/10.1111/eci.13072
Federal Statistical Office. (2024, April 24). Healthcare expenditure by providers. Statistisches Bundesamt (Destatis). https://www.destatis.de/DE/Themen/GesellschaftUmwelt/Gesundheit/Gesundheitsausgaben/Tabellen/ ausgabentraeger.html
HolonIQ. (2024). Global Health Tech unicorns. https://www.holoniq.com/ healthtech-unicorns
Institute for Health Metrics and Evaluation. (2024, August 2). Global burden of disease 2021: Findings from the GBD 2021 study. https://www.healthdata.org/researchanalysis/gbd
Kartanaite, I., & Krušinskas, R. (2023). Financial efficiency of unicorns: Regional and sector-related aspects. Engineering Economics, 33(2), 200-214. https://doi.org/10.5755/j01.ee.33.2.30798
Obermann, K., & Thielscher, C. (2022). Medical economics. Agenda Publishing.
Rösler, W., Altenbuchinger, M., Baeßler, B., Beissbarth, T., Beutel, G., Bock, R., von Bubnoff, N., Eckardt, J. N., Foersch, S., Loeffler, C. M. L., Middeke, J. M., Mueller, M. L., Oellerich, T., Risse, B., Scherag, A., Schliemann, C., Scholz, M., Spang, R., Thielscher, C., Tsoukakis, I., & Kather, J. N. (2023). An overview and a roadmap for artificial intelligence in hematology and oncology. Journal of Cancer Research and Clinical Oncology, 149(10), 7997- 8006. https://doi.org/10.1007/s00432-023-04667-5
Thielscher, C., & Kappler, K. (2023). Digitalization and organization of care: The case of oncology. Journal of European Economy, 22(1), 127-139. https://doi.org/10.35774/jee2023.01.127
Wharton, G. A., Sood, H. S., Sissons, A., & Mossialos, E. (2019). Virtual primary care: Fragmentation or integration? The Lancet Digital Health, 1(7), e330- e331. https://doi.org/10.1016/S2589-7500(19)30152-9
Yahoo Finance. (2024). TEM Holdings Limited profile. Retrieved August 3, 2024, from https://finance.yahoo.com/quote/TEM/profile/
Zenbusiness. (2024, May 2). Fastest unicorn companies. https://www.zenbusiness.com/ fastest-unicorns/
Received: June 20, 2024.
Reviewed: July 16, 2024.
Accepted: September 2, 2024.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
